Controversies about the treatment of myasthenia gravis.
Clinicians treating patients with myasthenia gravis must choose cholinergic drugs, corticosteroids, immunosuppressive drugs, thymectomy, or plasmapheresis. Clinicians must decide the sequence or combination of these therapies and when to deem lack of improvement a sign for a different therapeutic ap...
Na minha lista:
| Publicado no: | J Neurol Neurosurg Psychiatry |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1980
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490631/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7400825/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.43.7.644 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|